Light-emitting compound

Luminescent compounds with cross-linked biphenyl, terphenyl, or quaterphenyl skeletons address the lack of photostability and quantum yield in existing compounds, offering high absorbance, solvatochromism, and light resistance for bioimaging and electroluminescent applications.

JP2024166750AInactive Publication Date: 2024-11-29INSTITUTE OF SCIENCE TOKYO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023083070
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-19
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing luminescent compounds do not exhibit high photostability and fluorescence quantum yield both in solution and solid state, limiting their applications in analytical chemistry and bioimaging.

Method used

Development of luminescent compounds with partially cross-linked biphenyl, terphenyl, or quaterphenyl skeletons, featuring specific bridging units and electron-donating or electron-withdrawing groups, enhancing photostability and fluorescence quantum yield.

Benefits of technology

The compounds demonstrate high absorbance and fluorescence quantum yield in solution, significant solvatochromism, large Stokes shift, and high light resistance, making them suitable for bioimaging and electroluminescent devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024166750000001_ABST
    Figure 2024166750000001_ABST
Patent Text Reader

Abstract

To provide a novel light-emitting compound with high light stability, exhibiting high fluorescence quantum yield both in a solution and in its solid form and a method for producing the same.SOLUTION: The present invention provides a light-emitting compound represented by the general formula (1) (where W is hydrogen, an alkyl group, or an alkoxy group, X is CR1R2, NR3, SiR4R5, O, S, SO2, or POR6, Y is an electron-donating group, m is 0 or 1, Z is a formyl group, a carboxyl group, a cyano group, COR7, or CO2R7, R1-R5 and R7 are each an alkyl group or the like, and R6 is a substituted / unsubstituted phenyl group).SELECTED DRAWING: Figure 14B
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] One embodiment of the present invention relates to a luminescent compound and a method for producing the same. [Background technology]

[0002] Solvatochromic fluorescent dyes, which change their fluorescent color in response to the surrounding polar environment, are not only useful in analytical chemistry, especially bioimaging, but are also expected to be used in structural analysis of micelles and soft matter and as solid-state luminescent materials. For example, Non-Patent Document 1 discloses that push-pull pyrene derivatives can be used to identify sugar components in the structural analysis of a model of the lipid layer of a cell membrane. [Prior art documents] [Non-patent literature]

[0003] [Non-Patent Document 1] YOSUKE NIKO and 8 others, SCI REPORTS, 2016, Vol. 6, p. 18870 Summary of the Invention [Problem to be solved by the invention]

[0004] An object of one embodiment of the present invention is to provide a novel luminescent compound having a partially bridged biphenyl, terphenyl, or quaterphenyl skeleton and a method for producing the same. Alternatively, an object of one embodiment of the present invention is to provide a novel luminescent compound having high photostability and exhibiting high fluorescence quantum yield not only in a solution but also in a solid state, and a method for producing the same. [Means for solving the problem]

[0005] One embodiment of the present invention is a luminescent compound represented by the following general formula (1): where W is hydrogen, an alkyl group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms. X is CR 1 R 2 , N.R.3 , SiR 4 R 5 , O, S, SO2, or POR 6 R 1 and R 2 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, or CH2CH2(OCH2CH2) n R is a polyethylene glycol chain represented by OCH3. n is an integer of 1 or more. 3 , R 4 , and R 5 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, a phenyl group, or a substituted phenyl group. 6 is a phenyl group or a substituted phenyl group. The substituent of the substituted phenyl group is an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a diphenylamino group, or a monoalkylamino group or a dialkylamino group in which the substituent on the nitrogen is an alkyl group having 1 to 8 carbon atoms. Y is an electron donating group. m is 0 or 1. Z is a formyl group, a carboxyl group, a cyano group, a COR 7 , or CO2R 7 R 7 is an alkyl group or a substituted alkyl group having 1 to 8 carbon atoms. The substituent of the substituted alkyl group is a halogen, a hydroxyl group, an amino group, or an azide group. [ka]

[0006] One embodiment of the present invention is a luminescent compound represented by the following general formula (2): where W is hydrogen, an alkyl group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms. 1 and X 2 Independently, CR 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, SO2, or POR 6 R 1 and R 2 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, or CH2CH2(OCH2CH2)n R is a polyethylene glycol chain represented by OCH3. n is an integer of 1 or more. 3 , R 4 , and R 5 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, a phenyl group, or a substituted phenyl group. 6 is a phenyl group or a substituted phenyl group. The substituent of the substituted phenyl group is an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a diphenylamino group, or a monoalkylamino group or a dialkylamino group in which the substituent on the nitrogen is an alkyl group having 1 to 8 carbon atoms. Y is an electron donating group. m is 0 or 1. Z is a formyl group, a carboxyl group, a cyano group, a COR 7 , or CO2R 7 R 7 is an alkyl group or a substituted alkyl group having 1 to 8 carbon atoms. The substituent of the substituted alkyl group is a halogen, a hydroxyl group, an amino group, or an azide group. [ka] [Brief description of the drawings]

[0007] [Figure 1A] 1 shows absorption spectra of the luminescent compound 1-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl]-2,2,2-trifluoroethan-1-one (FRF) according to one embodiment of the present invention in various solvents. [Figure 1B] Emission spectra of FRF in various solvents. [Figure 2A] 1 shows absorption spectra of a luminescent compound 1-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)-2,2,2-trifluoroethan-1-one (N-FR-F) according to one embodiment of the present invention in various solvents. [Figure 2B] Emission spectra of N-FR-F in various solvents. [Figure 3A]1 shows absorption spectra of the luminescent compound methyl[7-(N,N-diethylamino)-9,9-dimethyl-9H-fluoren-2-yl]carboxylate (FCM) according to one embodiment of the present invention in various solvents. [Figure 3B] Emission spectra of FCM in various solvents. [Figure 4A] 1 shows absorption spectra of a light-emitting compound 1-{4-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl)]phenyl}-2,2,2-trifluoroethan-1-one (FRπF1) according to one embodiment of the present invention in various solvents. [Figure 4B] Emission spectra of FRπF1 in various solvents. [Figure 5A] 1 shows absorption spectra of a light-emitting compound 1-{[4-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)]phenyl}-2,2,2-trifluoroethan-1-one (FRπF2) according to one embodiment of the present invention in various solvents. [Figure 5B] Emission spectra of FRπF2 in various solvents. [Figure 6A] 1 shows absorption spectra of a light-emitting compound 1-{4-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl]-3-methylphenyl}-2,2,2-trifluoroethan-1-one (FRπMeF) according to one embodiment of the present invention in various solvents. [Figure 6B] Emission spectra of FRπMeF in various solvents. [Figure 7A] 1 shows absorption spectra of the luminescent compound methyl 4-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)benzoate (FπCM) in various solvents according to one embodiment of the present invention. [Figure 7B] Emission spectra of FπCM in various solvents. [Figure 8A] 1 shows absorption spectra of the luminescent compound methyl 4-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl]benzoate (FπpCM) in various solvents according to one embodiment of the present invention. [Figure 8B] Emission spectra of FπpCM in various solvents. [Figure 9A] 1 shows absorption spectra of the luminescent compound 2,2,2-trifluoro-1-{4-[6,6,12,12-tetramethyl-8-(piperidin-1-yl)-6,12-dihydroindeno[1,2-b]fluoren-2-yl]phenyl}ethan-1-one (IFπF) according to one embodiment of the present invention in various solvents. [Figure 9B] Emission spectra of IFπF in various solvents. [Figure 10A] 1 shows the absorption spectra of the luminescent compound 2,2,2-trifluoro-1-[6,6,12,12-tetramethyl-8-(piperidin-1-yl)-6,12-dihydroindeno[1,2-b]fluoren-2-yl]ethan-1-one (IFF) according to one embodiment of the present invention in various solvents. [Figure 10B] Emission spectra of IFF in various solvents. [Figure 11] Emission spectra of FπCM, FπA, and FRπF dispersed in a polymethylmethacrylate matrix. [Figure 12A] Stained image of model cells by FπCM. [Figure 12B] Image of mouse mammary epithelial cells stained with FπCM. [Figure 13] A plot of the change in emission intensity over time when a toluene solution of FπCM and Prodan was irradiated with 400 nm excitation light. [Figure 14A] Images of mouse mammary epithelial cells stained with Lurdan after 0, 10, and 30 minutes of irradiation with 405 nm excitation light. [Figure 14B] Images of mouse mammary epithelial cells stained with FπCM after irradiation with 405 nm excitation light for 0, 10, and 30 minutes. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0008] Hereinafter, each embodiment of the present invention will be described with reference to the drawings, etc. However, the present invention can be embodied in various forms without departing from the gist of the present invention, and should not be construed as being limited to the description of the embodiments exemplified below.

[0009] Hereinafter, an alkyl group is a monovalent substituent resulting from the loss of one hydrogen atom from an aliphatic hydrocarbon, and is defined as C n H 2n+1 n is an integer of 1 or more. Unless otherwise specified, alkyl groups include straight chain alkyl groups, branched alkyl groups, and cyclic alkyl groups. A substituted alkyl group refers to a monovalent substituent resulting from the replacement of one or more hydrogen atoms of an alkyl group with an atom other than a hydrogen atom or a substituent. As with an alkyl group, unless otherwise specified, a substituted alkyl group also includes substituted straight chain alkyl groups, substituted branched alkyl groups, and substituted cyclic alkyl groups. An alkoxy group is an alkoxy group that is an OC n H 2n+1 Similarly to alkyl groups, alkoxy groups include linear alkoxy groups, branched alkoxy groups, and cyclic alkoxy groups, unless otherwise specified.

[0010] Hereinafter, an amino group is a substituent represented by NH2, and an amino group in which one or two hydrogen atoms have been replaced by an atom other than hydrogen or a substituent is called a substituted amino group.

[0011] First Embodiment In this embodiment, the structure and properties of a luminescent compound according to one embodiment of the present invention will be described. The luminescent compound is a conjugated compound having a partially bridged biphenyl, terphenyl, or quaterphenyl skeleton. Specifically, the luminescent compound is a conjugated compound having two, three, or four benzene ring skeletons linked to each other at the para position, and in which some of the adjacent two benzene rings are bridged with carbon, nitrogen, oxygen, sulfur, silicon, or phosphorus. As demonstrated in the examples, the luminescent compound exhibits high absorbance and fluorescence quantum yield in solution, and also exhibits high fluorescence quantum yield in the solid state. Furthermore, it has high light resistance and can maintain its fluorescent properties for a long period of time. Therefore, the luminescent compound not only functions as a material that can be used in electroluminescent display devices, but is also useful in analytical chemistry, especially bioimaging.

[0012] 1. Luminescent compounds with one bridging unit (1) Structure A light-emitting compound according to one embodiment of the present invention is a fluorene compound represented by the following general formula (1): In general formula (1), m is 0 or 1. When m is 0, the light-emitting compound is a biphenyl derivative in the broad sense, and when m is 1, the light-emitting compound is a terphenyl derivative in the broad sense. [ka]

[0013] W is hydrogen, an alkyl group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms. X is a unit that bridges two benzene rings, and CR 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, SO2, or POR 6 Or, X is CR 1 R 2 , N.R. 3 , O, and S; CR 1 R 2 and N.R. 3Alternatively, X may be selected from CR 1 R 2 That's fine too.

[0014] R 1 and R 2 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, or CH2CH2(OCH2CH2) n The number average molecular weight of the polyethylene glycol chain is not limited and may be selected from the range of 100 to 2000. 3 , R 4 , and R 5 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, a phenyl group, or a substituted phenyl group. 6 is a phenyl group or a substituted phenyl group. Here, the substituent of the substituted phenyl group is selected from an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a diphenylamino group, or a monoalkylamino group or dialkylamino group in which the substituent on the nitrogen is an alkyl group having 1 to 8 carbon atoms. A further substituent (e.g., an alkyl group, an alkoxy group, etc.) may be introduced into the phenyl group of the diphenylamino group. In addition, there is no restriction on the substitution position on the substituted phenyl group, and it may be any of the ortho position, meta position, and para position.

[0015] Z is an electron-withdrawing substituent. Specifically, Z is a halogen (fluorine, chlorine, bromine, and iodine), a formyl group, a carboxyl group, a cyano group, a COR 7 , or CO2R 7 Preferably, Z is a carboxyl group, a cyano group, a COR 7 , or CO2R 7 Here, R 7is an alkyl group or a substituted alkyl group having 1 to 8 carbon atoms, and the substituent of the substituted alkyl group is a halogen, a hydroxyl group, an amino group, or an azide group. Therefore, the substituted alkyl group may be a perfluoroalkyl group, exemplified by a trifluoromethyl group, in which all of the hydrogen atoms of the alkyl group are substituted with fluorine. By using a perfluoroalkyl group, the electron-withdrawing property of Z can be increased. R 7 When is a substituted alkyl group, the substituent is R 7 For example, it may be attached to the terminal carbon of the substituted alkyl group, that is, the carbon farthest from the carbonyl carbon.

[0016] Y is an electron-donating group. Specifically, Y is an alkoxy group having 1 to 8 carbon atoms, an oxycarbonyl group, or an amino group or a substituted amino group, preferably a substituted amino group. Examples of the substituent bonded to the carbonyl carbon of the oxycarbonyl group include an alkyl group or a substituted alkyl group having 1 to 8 carbon atoms. Examples of the amino group and the substituted amino group include the substituents represented by the following structural formulas. [ka]

[0017] Here, k is an integer between 1 and 4. 8 , R 9 , R 10 , R 11 , and R 12 are independently hydrogen, an alkyl group having 1 to 10 carbon atoms, or a substituted alkyl group. 8 , R 9 , R 10 , R 11 , or R 12 When R is a substituted alkyl group, the substituent is a halogen, a carboxyl group, an ethynyl group, an azide group, an amido group, an amino group, or a diphenylphosphinophenyl group. 8 , R 9 , R 10 , R 11 , or R 12 When a substituted alkyl group is selected as R8 , R 9 , R 10 , R 11 , or R 12 The above substituents may be attached to any carbon of the substituted alkyl group, for example, they may be located at the terminus of the substituted alkyl group, i.e., on the carbon furthest from the nitrogen of the substituted amino group.

[0018] (2) Specific examples X is CR 1 R 2 In the case where the compound is represented by the formula (I), the compound is a fluorene derivative. Specific examples of the compound include the compounds shown below, but the compound is not limited to these compounds, and any compound falling within the scope of the above definition falls under the category of the compound.

[0019] [ka]

[0020] [ka]

[0021] [ka]

[0022] [ka]

[0023] X is NR 3 In the case where the compound is represented by the formula (I), the present light-emitting compound is a carbazole derivative. Specific examples of the compound include the compounds shown below, but the present light-emitting compound is not limited to these compounds, and any compound falling within the scope of the above definition corresponds to the present light-emitting compound.

[0024] [ka]

[0025] [ka]

[0026] [ka]

[0027] [ka]

[0028] When X is represented by O, the present luminescent compound is a dibenzofuran derivative. Specific examples of this case include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound.

[0029] [ka]

[0030] [ka]

[0031] [ka]

[0032] [ka]

[0033] When X is represented by S, the present luminescent compound is a dibenzothiophene derivative. Specific examples of this case include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound.

[0034] [ka]

[0035] [ka]

[0036] [ka]

[0037] [ka]

[0038] X is SiR 4 R 5 In the case where the compound is represented by the formula (I), the compound is a dibenzosilole derivative. Specific examples of the compound include the compounds shown below, but the compound is not limited to these compounds, and any compound falling within the scope of the above definition falls under the category of the compound.

[0039] [ka]

[0040] [ka]

[0041] [ka]

[0042] [ka]

[0043] X is POR 6In the case where the compound is represented by the formula (I), the compound is a dibenzophosphole oxide derivative. Specific examples of the compound include the compounds shown below, but the compound is not limited to these compounds, and any compound falling within the scope of the above definition falls under the compound.

[0044] [ka]

[0045] [ka]

[0046] [ka]

[0047] [ka]

[0048] When X is represented by SO2, the present luminescent compound is a dibenzothiophene dioxide derivative. Specific examples of this case include the following compounds, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition falls under the present luminescent compound.

[0049] [ka]

[0050] [ka]

[0051] [ka]

[0052] [ka]

[0053] 2. Luminescent compounds with two bridging units (1) Structure A luminescent compound according to another embodiment of the present invention is a compound represented by the following general formula (2): In general formula (2), m is 0 or 1. When m is 0, the luminescent compound is a terphenyl derivative in the broad sense, and when m is 1, the luminescent compound is a quaterphenyl derivative in the broad sense. [ka]

[0054] X 1 and X 2 are units that bridge two benzene rings, and are independently 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, SO2, or POR 6 Or, X 1 and X 2 Independently, CR 1 R 2 , N.R. 3 , O, and S; CR 1 R 2 and N.R. 3 Alternatively, you may choose from X 1 and X 2 is CR 1 R 2 X 1 and X 2 may be the same or different. For example, X 1 and X 2 Both are CR 1 R 2 If X 1 R included in 1 and R 2 are X 2 R included in 1 and R 2 X may be the same as or different from1 and X 2 NR 3 , SiR 4 R 5 , O, S, SO2, or POR 6 The same is true for the case where W, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, and Y and its substituent R 8 , R 9 , R 10 , R 11 , and R 12 Since the above is similar to the luminescent compound having one bridging unit, the explanation thereof will be omitted.

[0055] (2) Specific examples X 1 or X 2 CR 1 R 2 Specific examples of the present luminescent compound when represented by the formula (I) include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 Both are CR 1 R 2 However, X 1 and X 2 One of them is CR 1 R 2 and the other is NR 3 , SiR 4 R 5 , O, S, SO2, or POR 6 The compound represented by the following formula is also included in the present luminescent compound.

[0056] [ka]

[0057] [ka]

[0058] [ka]

[0059] [ka]

[0060] X 1 or X 2 NR 3 Specific examples of the compound represented by the formula (I) include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 Both are NR 3 However, X 1 and X 2 One of them is NR 3 and the other is CR 1 R 2 , SiR 4 R 5 , O, S, SO2, or POR 6 The compound represented by the following formula is also included in the present luminescent compound.

[0061] [ka]

[0062] [ka]

[0063] [ka]

[0064] [ka]

[0065] X1 or X 2 Specific examples of the present luminescent compound when is represented by O include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 are both O, but X 1 and X 2 One of them is represented by O and the other is CR 1 R 2 , N.R. 3 , SiR 4 R 5 , S, SO2, or POR 6 The compound represented by the following formula is also included in the present luminescent compound.

[0066] [ka]

[0067] [ka]

[0068] [ka]

[0069] [ka]

[0070] X 1 or X 2 Specific examples of the compound represented by S include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 are both S, but X 1 and X 2 One of them is represented by S and the other is CR 1 R 2 , N.R.3 , SiR 4 R 5 , O, SO2, or POR 6 The compound represented by the following formula is also included in the present luminescent compound.

[0071] [ka]

[0072] [ka]

[0073] [ka]

[0074] [ka]

[0075] X 1 or X 2 SiR 4 R 5 Specific examples of the compound represented by the formula (I) include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 Both are SiR 4 R 5 However, X 1 and X 2 One of them is SiR 4 R 5 and the other is CR 1 R 2 , N.R. 3 , O, S, SO2, or POR 6 The compound represented by the following formula is also included in the present luminescent compound.

[0076] [ka]

[0077] [ka]

[0078] [ka]

[0079] [ka]

[0080] X 1 or X 2 Specific examples of the present luminescent compound when is represented by SO2 include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 Both are SO2, but X 1 and X 2 One of them is represented by SO2 and the other is CR 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, or POR 6 The compound represented by the following formula is also included in the present luminescent compound.

[0081] [ka]

[0082] [ka]

[0083] [ka]

[0084] [ka]

[0085] X 1 or X 2 POR 6 Specific examples of the present luminescent compound when represented by the formula (I) include the compounds shown below, but the present luminescent compound is not limited to these, and any compound falling within the scope of the above definition corresponds to the present luminescent compound. For example, in the example shown below, X 1 and X 2 Both are POR 6 However, X 1 and X 2 One of them is POR 6 and the other is CR 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, or SO2 are also included in the luminescent compound.

[0086] [ka]

[0087] [ka]

[0088] [ka]

[0089] [ka]

[0090] 3. Characteristics of luminescent compounds As shown in the examples, the above-mentioned luminescent compound exhibits a large extinction coefficient in the ultraviolet region (approximately 370 nm to 390 nm) in a solution, and exhibits strong fluorescence in the visible light region. Although it depends on the solvent, the fluorescence quantum yield reaches about 30% to 90%. Furthermore, it exhibits a broad-sense solvatochromism in which the fluorescence peak wavelength changes depending on the solvent. In addition, although it depends on the solvent and the substituent, it exhibits a large Stokes shift that reaches 310 nm. Therefore, it is possible to control the emission wavelength by appropriately selecting the substituent, and it is possible to absorb light around 405 nm, which is widely used as excitation light, and emit light of a relatively long wavelength (for example, a wavelength in the red region). Since light in the red region has high biological permeability, it can be said that this luminescent compound is useful as a probe dye for bioimaging.

[0091] Furthermore, this luminescent compound can emit light with a relatively high fluorescence quantum yield even in the solid state. For example, Z is an ester group (COR 7 ), the compound can exhibit a fluorescence quantum yield of nearly 80% even when dispersed in a matrix. In addition, the luminescent compound has high light resistance, and even when irradiated with excitation light for a long period of time in a solution or in a solid state, fading or a decrease in fluorescence quantum yield is hardly observed. Therefore, the luminescent compound can be used as a probe dye with high stability over a long period of time, and can also be useful as a host or dopant in the light-emitting layer of an electroluminescent device.

[0092] <Second embodiment> In this embodiment, a method for producing the luminescent compound described in the first embodiment will be described. However, the production method described below is merely an example, and the luminescent compound can also be produced via various other routes.

[0093] 1. Luminescent compounds with one bridging unit (1) X is CR 1 R 2 in the case of When the present light-emitting compound is a fluorene derivative, the present light-emitting compound can be produced, for example, according to the following scheme: Here, L is a leaving group, typically exemplified by halogen such as bromine or iodine, trifluoromethanesulfonyl group, fluorosulfonyl group, and paratoluenesulfonyl group. [ka]

[0094] In the production method according to this scheme, fluorene having leaving groups L at the 2-position and 7-position is used as a starting material, and the methylene group at the 9-position is alkylated. The alkylation can be carried out by abstracting a proton with a base, followed by a reaction with an alkylating agent such as an alkyl iodide. Then, an electron donating group Y is introduced to one of the leaving groups L. For example, when Y is an amino group, it can be reacted with the corresponding amine (YH) by using a coupling reaction using a metal catalyst such as a palladium catalyst, as in the above scheme. Then, the other leaving group can be used for transmetalation and reacted with the corresponding carbonyl compound. The transmetalation can be lithiation or Grignardization. Examples of carbonyl compounds include N,N-dimethylformamide (DMF), N,N-dimethyltrifluoroacetamide, and carbon dioxide (dry ice). When Z is a cyano group, dehydration of the corresponding amide group can be used. When Z is an ester group, a carboxyl group may be introduced as Z, followed by esterification with an acid catalyst, or conversion of the carboxyl group to a carbonyl chloride and reaction with an alcohol.

[0095] When m is 1 in general formula (1), as shown in the following scheme, Y is introduced using one of the leaving groups L, and then phenylboronic acid or a phenylboronic acid ester having an electron-withdrawing group Z is coupled using a palladium catalyst or the like. [ka]

[0096] (2) X is NR 3 , SiR 4 R 5 , O, S, SO 2 , or POR 6 in the case of X is NR 3 , SiR 4 R 5 , O, S, SO 2 , or POR 6 The same is true in the case of the above. That is, as shown in the following scheme, a carbazole derivative, a dibenzosilole derivative, a dibenzofuran derivative, a dibenzothiophene derivative, a dibenzothiophene dioxide derivative, or a dibenzophosphole oxide derivative having a leaving group L is used, and one of the leaving groups L is converted to Y by a coupling reaction. Then, a carbonyl group, a carboxyl group, an amide group, or the like can be introduced using the other leaving group L.

[0097] [ka]

[0098] The dibenzothiophene dioxide derivatives can be obtained by oxidizing the corresponding dibenzothiophenes with an oxidizing agent such as hydrogen peroxide, peracetic acid, perbenzoic acid, m-chloroperbenzoic acid, tert-butyl peroxide, or sodium metaperiodate. The dibenzophosphole oxide derivatives can be obtained by oxidizing the corresponding 5-halo-5-hydrodibenzophosphole-5-oxide derivatives and 6 The corresponding aryllithium (i.e., R 6 Li) or aryl magnesium halides (e.g., R 6 MgX 1 , X 1 can be obtained by reacting the corresponding 5-hydrodibenzophosphole with R (see the following formula, not shown). 6 Alternatively, the corresponding aryl metal or the like may be coupled in the presence of a palladium catalyst, and then oxidized with an oxidizing agent such as hydrogen peroxide. [ka]

[0099] 2. Luminescent compounds with two bridging units As with the present luminescent compound represented by general formula (1), the present luminescent compound represented by general formula (2) can be prepared by synthesizing a terphenyl skeleton having two leaving groups L introduced therein by applying a known method as appropriate, and then introducing Y and Z thereinto by a coupling reaction using a metal catalyst such as a palladium catalyst. There are no limitations on the method for synthesizing the terphenyl skeleton, and the compound can be synthesized by various routes. For example, X 1 and X 2 Both are CR 1 R 2 In the case of the above, as shown in the scheme below, 2,5-dibromo-p-xylene is used as the starting material, and a terphenyl skeleton (fluorene derivative) with bromine introduced as the leaving group L can be obtained by introducing a phenyl group using Suzuki coupling, oxidizing the methyl group and subsequent dehydration cyclization, reducing the carbonyl group, alkylating the methylene group, and brominating the terminal benzene ring. [ka] EXAMPLES

[0100] In this example, the synthesis of a luminescent compound according to one embodiment of the present invention and the evaluation of its characteristics will be described.

[0101] 1. Equipment 1 H-NMR spectrum and 13 C-NMR spectra were obtained by measuring CDCl3 or DMSO-d6 solutions using tetramethylsilane as an internal standard on a BRUKER 500 (500 MHz) spectrophotometer. 1 H-NMR data is described by chemical shift (δ, in ppm), signal multiplicity (s for singlet, d for doublet, t for triplet, m for multiplet), integral ratio, and coupling constant (J, in Hz). 13C-NMR data are described by chemical shifts (δ, in ppm). UV-visible spectra were measured using a JASCO V-670 UV-visible spectrophotometer. Fluorescence spectra were measured using a JASCO FP-6500 spectrofluorometer. Fluorescence quantum yields (absolute quantum yields) were measured using a Hamamatsu Photonics Quantaurus-QY absolute PL quantum yield measurement system. Fluorescence lifetimes were measured using a HORIBA time-correlated single photon counting method.

[0102] 2. Synthesis of luminescent compounds (1) 1-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl]-2,2,2-trifluoroethan-1-one (FRF) FRF was synthesized according to the following scheme. [ka]

[0103] Under an argon atmosphere, potassium t-butoxide (4.94 g, 44 mmol) was added to a solution of 2,7-dibromo-9H-fluorene (6.48 g, 20 mmol) in tetrahydrofuran (THF, 100 mL) at 0°C, and the reaction solution was stirred at room temperature. After 1.5 hours, methyl iodide (2.5 mL, 40 mmol) was added, and the mixture was further stirred at room temperature for 2 hours. The reaction solution was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)), and 2,7-dibromo-9,9-dimethyl-9H-fluorene was obtained as a white solid in a yield of 90%. 1 H-NMR (500MHz, CDCl3): δ7.54(t,J=4.0Hz,4H),7.46(d,J=7.9Hz,2H),1.46(s,6H)

[0104] 2,7-Dibromo-9,9-dimethyl-9H-fluorene (3.5 g, 10 mmol), potassium t-butoxide (1.06 g, 11 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP, 0.74 g, 1.2 mmol), and palladium acetate (90 mg, 0.40 mmol) were dissolved in toluene (100 mL) and stirred at 100 °C. One equivalent of piperidine was added to 2,7-dibromo-9,9-dimethyl-9H-fluorene, and the reaction mixture was stirred at 100 °C for 4 hours. The reaction solution was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography to obtain 1-(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)piperidine as a white solid in a 42% yield. 1 H-NMR (500MHz, CDCl3): δ7.54(d,J=8.2Hz,1),7.48(s,1H),7.44(d,J=7.9Hz,1H),7.39(d,J=7.9Hz,1H), 6.98(s,1H),6.91(d,J=7.6Hz,1H),3.22(t,J=5.2Hz,4H),1.75(s,4H),1.61(t,J=5.8Hz,2H),1.44(s,6H)

[0105] A hexane solution of n-butyllithium (2.3 M, 1.57 mL, 3.6 mmol) was added to a solution of 1-(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)piperidine (1.07 g, 3.0 mmol) in THF (10 mL) at -78 °C. After 1 hour, 2,2,2-trifluoro-N,N-dimethylacetamide (0.40 mL, 3.6 mmol) was added and stirred at -78 °C for another 2 hours. The reaction mixture was quenched with a saturated aqueous solution of sodium bicarbonate, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)) to obtain FRF as a yellow solid in 45% yield. 1H-NMR (500MHz, CDCl3): δ8.06(s,1H),8.02(d,J=8.2Hz,1H),7.67(d,J=3.7Hz,1H),7.65(d,J=4.0Hz,1H),6.97(d,J= 1.8Hz,1H),6.94(dd,J=8.5,2.1Hz,1H),3.31(t,J=5.3Hz,4H),1.77-1.72(m,4H),1.64(q,J=5.7Hz,2H),1.49(s,6H)

[0106] (2) 1-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)-2,2,2-trifluoroethan-1-one (N-FR-F) N-FR-F was synthesized according to the following scheme. [ka]

[0107] 2,7-Dibromo-9,9-dimethyl-9H-fluorene (1.76 g, 5.0 mmol), sodium t-butoxide (0.53 g, 5.5 mmol), BINAP (0.37 g, 0.60 mmol), and palladium acetate (45 mg, 0.20 mmol) were dissolved in toluene (50 mL) and stirred at 100 °C. Dimethylamine (0.63 mL, 6.0 mmol) was added, and the reaction mixture was stirred at 100 °C for 2 h. The reaction solution was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography to obtain diethyl(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)amine as a yellow solid in 22% yield. 1 H-NMR (500MHz, CDCl3): δ7.50(d,J=8.2Hz,1H),7.44(s,1H),7.39(d,J=7.9Hz,1H),7.36(d,J=8.2 Hz,1H),6.67(s,1H),6.66-6.64(m,1H),3.41(q,J=7.0Hz,4H),1.44(s,6H),1.20(t,J=7.0Hz,6H)

[0108] A solution of diethyl(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)amine (1.1 g, 3.0 mmol) in THF (10 mL) was added with a hexane solution of n-butyllithium (2.6 M, 1.4 mL, 3.6 mmol) at -78 °C. After 1 hour, 2,2,2-trifluoro-N,N-dimethylacetamide (0.40 mL, 3.6 mmol) was added and stirred at -78 °C for another 2 hours. The reaction mixture was quenched with a saturated aqueous solution of sodium bicarbonate, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography and recrystallized with methylene chloride and hexane to obtain N-FR-F as a yellow solid in 60% yield. 1 H-NMR (500MHz, CDCl3): δ8.03(s,1H),8.00(d,J=7.9Hz,1H),7.64-7.60(m,2H), 6.70(d,J=7.3Hz,2H),3.46(q,J=7.1Hz,4H),1.49(s,6H),1.24(t,J=7.0Hz,6H)

[0109] (3) Methyl [7-(N,N-diethylamino)-9,9-dimethyl-9H-fluoren-2-yl] carboxylate (FCM) FCM was synthesized according to the following scheme. [ka]

[0110] Under an argon atmosphere, n-butyllithium (1.6M, 2.88mL, 7.5mmol) was added dropwise to a solution of diethyl(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)amine (1.72g, 5.0mmol) in THF (15mL). The solution was stirred at -78°C for 30 minutes, warmed to room temperature, poured into dry ice, and stirred for 2 hours. The reaction mixture was then treated with 20% hydrochloric acid, filtered, and the precipitate was washed with water and dried under reduced pressure. A solution of this precipitate and p-toluenesulfonic acid (0.10g, 0.50mol) in methanol (15mL) was refluxed for 18 hours. After cooling, the reaction solution was extracted with methylene chloride, the organic layer was washed with water and saturated saline, dried over magnesium sulfate, filtered, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane / ethyl acetate (3 / 1, v / v)) to obtain FCM as a yellow solid in a yield of 67%. 1 H-NMR (500MHz, CDCl3): δ8.05(d,J=10.4Hz,2H),7.59(dd,J=10.5,8.4Hz,2H),6.70 -6.68(m,2H),3.90(s,3H),3.45(q,J=7.1Hz,3H),1.49(s,4H),1.23(t,J=7.2Hz,4H)

[0111] (4) 1-{4-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl)]phenyl}-2,2,2-trifluoroethan-1-one (FRπF1) FRπF1 was synthesized according to the following scheme. [ka]

[0112] A suspension of 1-(4-bromophenyl)-2,2,2-trifluoroethan-1-one (1.01 g, 4.0 mmol), bis(pinacolato)diboron (1.32 g, 5.2 mmol), potassium acetate (1.18 g, 12 mmol), and Pd(dppf)Cl2·CH2Cl2 (0.163 g, 0.20 mmol) in 1,4-dioxane (5 mL) was stirred overnight at 50 °C under an argon atmosphere. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / ethyl acetate (3 / 1, v / v), hexane / methylene chloride (3 / 1, v / v)) to obtain 2,2,2-trifluoro-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one as a colorless oil in a yield of 89%. 1 H-NMR (500MHz, CDCl3): δ8.04(d,J=7.3Hz,2H,H),7.96(d,J=8.5Hz,2H),1.37(s,12H)

[0113] Under an argon atmosphere, 1-(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)piperidine (0.45 g, 1.2 mmol), 2,2,2-trifluoro-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one (0.43 g, 1.4 mmol), potassium phosphate (0.76 g, 4.5 mmol), and tetrakis(triphenylphosphine)palladium (Pd(PPh3)4, 49 mg, 0.06 mmol) were dissolved in a THF / H2O mixed solvent (5 / 1, v / v, 10 mL). The solution was stirred at 50°C overnight. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)) and then recrystallized from hexane and methylene chloride (4 / 1, v / v) to obtain FRπF1 as a red solid in a 32% yield. 1H-NMR (500MHz, CDCl3):8.18(d,J=7.9Hz,2H),7.85(d,J=8.5Hz,2H),7.72(d,J=7.6Hz,1H),7.67-7.64(m,2H),7.62(d,J=7.9Hz) ,1H),7.05(d,J=1.5Hz,1H),6.97(d,J=8.5Hz,1H),3.29(t,J=5.5Hz,4H),1.81-1.76(m,4H),1.65(q,J=5.8Hz,2H),1.55(s,6H)

[0114] (5) 1-{[4-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)]phenyl}-2,2,2-trifluoroethane-1-one (FRπF2) FRπF2 was synthesized according to the following scheme. [ka]

[0115] Under an argon atmosphere, diethyl(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)amine (0.38 g, 1.1 mmol), 2,2,2-trifluoro-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one (0.40 g, 1.3 mmol), potassium phosphate (0.70 g, 3.3 mmol), and Pd(PPh3)4 (64 mg, 0.22 mmol) were dissolved in a THF / H2O mixed solvent (5 / 1, v / v, 6 mL). The solution was stirred at 50°C overnight. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)) and then recrystallized from hexane and methylene chloride (4 / 1, v / v) to obtain FRπF2 as a red solid in a 53% yield. 1H-NMR (500MHz, CDCl3): δ8.15(d,J=7.9Hz,2H),7.82(d,J=8.5Hz,2H),7.65-7.62(m,2H),7.60-7.57(m ,2H),6.73(s,1H),6.69(d,J=8.5Hz,1H),3.45(q,J=7.0Hz,4H),1.52(s,6H),1.23(t,J=7.0Hz,6H,CH3)

[0116] (6) Methyl 4-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)benzoate (FπCM) FπCM was synthesized according to the following scheme. [ka]

[0117] Under an argon atmosphere, diethyl(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)amine (1.32 g, 3.0 mmol), 4-methoxycarbonylphenylboronic acid (0.809 g, 4.5 mmol), potassium phosphate (2.19 g, 9.0 mmol), and Pd(PPh3)4 (0.173 mg, 0.15 mmol) were dissolved in a toluene / water / methanol mixed solvent (5 / 1 / 2, v / v·v, 10 mL). The solution was stirred at 100 °C for 6 h. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane / ethyl acetate (3 / 1, v / v)) and then recrystallized from hexane / methylene chloride (3 / 1, v / v) to obtain FπCM as a yellow solid in a 78% yield. 1 H-NMR (500MHz, CDCl3): δ8.10(d,J=8.2Hz,2H),7.72(d,J=8.2Hz,2H),7.63-7.54(m,4H),6.73 -6.68(m,2H),3.94(s,3H,OCH3),3.44(q,J=7.0Hz,4H),1.52(s,6H),1.23(t,J=7.0Hz,6H)ppm

[0118] (7) 1-[4-(7-diethylamino-9,9-dimethyl-9H-fluoren-2-yl)phenyl]ethan-1-one (FπA) FπA was synthesized according to the following scheme. [ka]

[0119] Under an argon atmosphere, diethyl(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)amine (0.69 g, 2.0 mmol), 4-acetylphenylboronic acid (0.49 g, 3.0 mmol), potassium phosphate (1.46 g, 6.0 mmol), and Pd(PPh3)4 (0.115 mg, 0.10 mmol) were dissolved in a toluene / water / methanol mixed solvent (5 / 1 / 2, v / v·v, 10 mL). The solution was stirred at 100 °C for 6 h. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / ethyl acetate (3 / 1, v / v)) and then recrystallized from hexane / methylene chloride (3 / 1, v / v) to obtain FπA as a yellow solid in an 88% yield. 1 H-NMR (500MHz, CDCl3): δ8.03(d,J=8.2Hz,2H),7.74(d,J=8.2Hz,2H),7.63-7.54(m,4H), 6.73-6.68(m,2H),3.44(q,J=7.0Hz,4H),2.64(s,3H),1.52(s,6H),1.23(t,J=7.0Hz,6H)

[0120] (8) 1-{4-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl]-3-methylphenyl}-2,2,2-trifluoroethane-1-one (FRπMeF) FRπMeF was synthesized according to the following scheme. [ka]

[0121] Tetrabutylammonium fluoride (TBAF, 0.13 mL, 0.13 mmol) was added to a solution of methyl 4-bromo-3-methylbenzoate (1.15 g, 5.0 mmol) and trifluoromethyltrimethylsilane (CF3TMS) (0.93 mL, 6.3 mmol) in toluene (15 mL) at -78°C under an argon atmosphere, and the mixture was stirred for another 2 hours. The reaction mixture was quenched with a saturated aqueous solution of sodium bicarbonate, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)) to obtain 1-(4-bromo-3-methylphenyl)-2,2,2-trifluoroethan-1-one as a yellow solid in a yield of 90%. 1 H-NMR (500MHz, CDCl3): δ7.92(d,1H),7.73(d,2H),2.50(s,3H)

[0122] A suspension of 1-(4-bromo-3-methylphenyl)-2,2,2-trifluoroethan-1-one (1.2 g, 4.5 mmol), bis(pinacolato)diboron (1.5 g, 5.9 mmol), potassium acetate (1.3 g, 14 mmol), and Pd(dppf)Cl2·CH2Cl2 (0.18 g, 0.23 mmol) in 1,4-dioxane (5 mL) was stirred overnight at 50 °C under an argon atmosphere. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / ethyl acetate (3 / 1, v / v), hexane / methylene chloride (3 / 1, v / v)) to obtain 1-[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one as a colorless oil in a 63% yield. 1 H-NMR (500MHz, CDCl3): δ7.89(d,J=7.6Hz,1H),7.82(d,J=8.9Hz,2H),2.61(s,3H,CH3),1.36(s,12H)

[0123] Under an argon atmosphere, 1-(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)piperidine (0.47 g, 1.3 mmol), 1-[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one (0.50 g, 1.6 mmol), potassium phosphate (0.84 g, 3.9 mmol), and Pd(PPh3)4 (77 mg, 0.065 mmol) were dissolved in a THF / H2O mixed solvent (5 / 1, v / v, 9 mL). The solution was stirred at 50°C overnight. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane / methylene chloride (3 / 1, v / v)) and then recrystallized from hexane and methylene chloride (4 / 1, v / v) to obtain FRπMeF as a red solid in a 41% yield. 1 H-NMR (500MHz, CDCl3): δ8.00(s,1H),7.95(d,J=7.9Hz,1H),7.66(d,J=7.6Hz,1H),7.62(d,J=8.5Hz,1H),7.48(d,J=8.2Hz,1H),7.32(s,1H),7 .25(d,J=7.0Hz,1H),7.02(s,1H),6.94(d,J=8.2Hz,1H),3.25(t,J=5.3 Hz,4H),2.42(s,3H),1.78-1.74(m,4H),1.64-1.59(m,2H),1.49(s,6H)

[0124] (9) Methyl 4-[9,9-dimethyl-7-(piperidin-1-yl)-9H-fluoren-2-yl]benzoate (FπpCM) FπpCM was synthesized according to the following scheme. [ka]

[0125] Under an argon atmosphere, 1-(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)piperidine (1.07 g, 3.0 mmol), 4-methoxycarbonylphenylboronic acid (0.809 g, 4.5 mmol), potassium phosphate (2.19 g, 9.0 mmol), and Pd(PPh3)4 (173 mg, 0.15 mmol) were dissolved in a toluene / H2O / methanol mixed solvent (5 / 1 / 2, v / v / v, 10 mL). The solution was stirred at 100 °C for 6 h. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane / ethyl acetate (3 / 1, v / v)) and then recrystallized from hexane / methylene chloride (3 / 1, v / v) to obtain FπpCM as a yellow solid in 88% yield. 1 H-NMR (500MHz, CDCl3): δ8.11(d,J=7.9Hz,2H),7.72(d,J=8.2Hz,2H),7.68-7.56(m,4H),7.03(d,J=11.0Hz,1H ),6.94(d,J=8.2Hz,1H),3.95(s,3H),3.25(t,J=5.3Hz,4H),1.78-1.74(m,4H),1.64-1.59(m,2H),1.51(s,6H)

[0126] (10) 2,2,2-trifluoro-1-{4-[6,6,12,12-tetramethyl-8-(piperidin-1-yl)-6,12-dihydroindeno[1,2-b]fluoren-2-yl]phenyl}ethan-1-one (hereinafter, IFπF) IFπF was synthesized according to the following scheme. [ka]

[0127] Under an argon atmosphere, 2,5-dibromo-p-xylene (2.64 g, 10 mmol), phenylboronic acid (2.56 g, 21 mmol), potassium phosphate (6.37 g, 30 mmol), and Pd(PPh3)4 (0.58 g, 0.5 mmol) were dissolved in a toluene / ethanol / H2O mixed solvent (4 / 1 / 1, v / v / v, 120 mL). The solution was stirred at 90°C for 23 hours. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)), to obtain 2',5'-dimethyl-1,1':4'1"-terphenyl as a white solid in a yield of 99%. 1 H-NMR (500MHz, CDCl3): δ7.42(d,J=7.3Hz,4H),7.37(dd,J=11.7,7.8Hz,6H),7.16(s,2H),2.28(s,6H)

[0128] 2',5'-Dimethyl-1,1':4'1"-terphenyl (2.55 g, 9.86 mmol) was mixed with 60 mL of pyridine and KMnO4 (7 g, 44.3 mmol) and stirred at reflux temperature for 2 h. Every 30 min, 10 mL of water and KMnO4 (3 g, 19.0 mmol) were added over 4 h. After 5 h, 60 mL of water was added and reflux was maintained overnight. MoO4 was removed by filtration and washed with boiling water. The filtrate was concentrated and concentrated hydrochloric acid was added to precipitate 1,1':4'1"-terphenyl-2',5'-dicarboxylic acid as a white solid in 73% yield. 1 H-NMR (500MHz, DMSO-D6): δ7.67(s,2H),7.47-7.41(m,10H)

[0129] 1,1':4'1"-terphenyl-2',5'-dicarboxylic acid (2.3 g, 7.2 mmol) was added to 50 mL of sulfuric acid and stirred at room temperature for 2 hours. 50 mL of cold water was added, and the precipitate was filtered and dried under reduced pressure. The precipitate was stirred in a saturated aqueous potassium carbonate solution for 1.5 hours, filtered, and dried under reduced pressure to obtain indeno[1,2-b]-6,12-dione as a purple solid in a yield of 80%. 1 H-NMR (500MHz, CDCl3): δ7.82(s,2H),7.70(d,J=7.3Hz,2H),7.57(d,J=5.8Hz,4H),7.36(d,J=7.2Hz)

[0130] Indeno[1,2-b]-6,12-dione (1.6 g, 5.8 mmol) was dissolved in triethoxysilane / trifluoroacetic acid (1 / 3, v / v, 40 mL), and the resulting solution was stirred at room temperature for 2 h. Volatile components were removed under reduced pressure, and hexane was added to the residue and stirred for 2 h. The precipitate was filtered and dried under reduced pressure to obtain 6,12-dihydroindeno[1,2-b]fluorene as a white solid in 100% yield. 1 H-NMR (500MHz, CDCl3): δ7.72-7.80(2H),7.41-7.48(1H),7.27-7.38(2H),1.54-1.58(4H,)

[0131] Under an argon atmosphere, indeno[1,2-b]-6,12-dione (1.5 g, 5.8 mmol) was dissolved in THF (50 mL), potassium t-butoxide (3.3 g, 29 mmol) was added at 0°C, and the reaction mixture was stirred at room temperature. After 1.5 hours, methyl iodide (3.6 mL, 58 mmol) was added, and the mixture was stirred at room temperature for another 2 hours. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)) to obtain a white solid. This white solid was recrystallized with methylene chloride and hexane to obtain 6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluorene in a yield of 26%. 1H-NMR (500MHz, CDCl3): δ7.77(d,J=6.7Hz,4H),7.44(d,J=7.3Hz,2H),7.35(t,J=7.3Hz,2H),7.30(t,J=7.3Hz,2H),1.55(s,12H)

[0132] A solution of bromine (0.43 mL, 8.3 mmol) in chloroform (10 mL) was added to a suspension of 6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluorene (1.21 g, 3.9 mmol) and iron(III) chloride (64 mg, 0.39 mmol) in chloroform (30 mL), and the mixture was stirred at room temperature for 4 h. The reaction mixture was quenched with saturated aqueous sodium thiosulfate, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure to give 2,8-dibromo-6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluorene as a white solid in 83% yield. 1 H-NMR (500MHz, CDCl3): δ7.70(s,2H),7.61(d,J=7.9Hz,2H),7.56(s,2H),7.47(dd,J=7.9,1.2Hz,2H),1.53(s,12H)

[0133] Under an argon atmosphere, piperidine (0.41 mL, 4.2 mmol) was added to a solution of 2,8-dibromo-6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluorene (1.9 g, 4.2 mmol), potassium t-butoxide (0.70 g, 6.2 mmol), tri(o-tolyl)phosphine (0.26 g, 0.83 mmol), and palladium acetate (93 mg, 0.20 mmol) in toluene (40 mL) at 100° C., and the reaction mixture was stirred at 100° C. for 2 hours. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a white solid. This white solid was recrystallized from methylene chloride and hexane to give 1-(8-bromo-6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluoren-2-yl)piperidine as a yellow solid in a 39% yield. 1 H-NMR (500MHz, CDCl3): δ7.64(s,1H),7.62(s,1H),7.60-7.56(m,2H),7.52(s,1H),7.44(d,J=8.5Hz, 1H),7.01(s,1H),6.92(d,J=8.5Hz,1H),3.23(s,4H),1.75(s,4H),1.60(d,J=5.8Hz,2H),1.51(s,6H)

[0134] Under an argon atmosphere, a solution of 1-(8-bromo-6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluoren-2-yl)piperidine (0.42 g, 0.89 mmol), 2,2,2-trifluoro-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethan-1-one (0.19 g, 0.63 mmol), potassium phosphate (0.57 g, 2.7 mmol), and Pd(PPh3)4 (51 mg, 0.044 mmol) in toluene (10 mL) was stirred at 80° C. overnight. The reaction mixture was quenched with water, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: hexane / methylene chloride (3 / 1, v / v)) and then recrystallized from hexane / methylene chloride (1 / 3, v / v) to obtain IFπF as a yellow solid in a 16% yield. 1 H-NMR (500MHz, CDCl3): δ8.17(d,J=7.9Hz,2H),7.85(d,J=8.5Hz,2H),7.83(d,J=7.9Hz,1H),7.74(s,1H),7.69(s,1H),7.66(d,J=4.9Hz,2H) ,7.63(s,1H),7.03(s,1H),6.95(d,J=8.2Hz,1H),3.25(t,J=5.2Hz,4H),1.76(d,J=5.2Hz,4H),1.64-1.62(m,2H),1.59(s,6H),1.54(s,6H). 13 C-NMR (100MHz, CDCl3): δ180.6,180.2,179.9,155.8,155.2,154.0,153.3,149.1,141.1,140.3,137.5,136.6,131.1,128 .5,127.8,126.8,121.8,120.7,120.4,118.6,115.8,114.7,114.3,113.5,111.4,51.6,47.0,46.9,28.0,27.8,26.3,24.6

[0135] (10) 2,2,2-trifluoro-1-[6,6,12,12-tetramethyl-8-(piperidin-1-yl)-6,12-dihydroindeno[1,2-b]fluoren-2-yl]ethan-1-one (IFF) IFF was synthesized according to the following scheme. [ka]

[0136] Under an argon atmosphere, 1-(8-bromo-6,6,12,12-tetramethyl-6,12-dihydroindeno[1,2-b]fluoren-2-yl)piperidine (0.224 g, 0.47 mmol) in THF (2 mL) was added with 2.3 M n-butyllithium in hexane (0.25 mL, 0.58 mmol) at -78 °C. After 1 hour, 2,2,2-trifluoro-N,N-dimethylacetamide (0.06 mL, 0.58 mmol) was added and the mixture was stirred at -78 °C for another 2 hours. The reaction mixture was quenched with saturated aqueous sodium bicarbonate solution, and the organic matter was extracted with methylene chloride. The organic layer was washed with water and saturated saline, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane / ethyl acetate (3 / 1, v / v)) and further recrystallized from hexane / methylene chloride (1 / 3, v / v) to obtain IFF as a red solid in a yield of 48%. 1 H-NMR (500MHz, CDCl3): δ8.11(s,1H),8.08(d,J=8.2Hz,1H),7.83(d,J=8.2Hz,1H),7.77(s,1H),7.66(d,J=10.4Hz,2H),7.0 2(s,1H),6.95(d,J=8.5Hz,1H),3.28-3.24(m,4H),1.76(d,J=4.6Hz,4H),1.62(t,J=5.6Hz,2H),1.57(s,6H,3),1.53(s,6H)

[0137] 3.Characteristics (1) Optical properties in solution The absorption and emission spectra in various solvents of the luminescent compounds, FRF, N-FR-F, FCM, FRπF1, FRπF2, FRπMeF, FπCM, FπpCM, IFπF, and IFF, synthesized in the above synthesis examples, are shown in Figures 1A to 10B. The spectral data of these luminescent compounds are summarized in Tables 1 to 10 below. In each table, ε is the extinction coefficient, λ abs is the absorption maximum wavelength, λ fl is the emission maximum wavelength, Φ fl is the emission quantum yield.

[0138] [Table 1]

[0139] [Table 2]

[0140] [Table 3]

[0141] [Table 4]

[0142] [Table 5]

[0143] [Table 6]

[0144] [Table 7]

[0145] [Table 8]

[0146] [Table 9]

[0147] [Table 10]

[0148] As can be seen from Figures 1A to 10B and Tables 1 to 10, it was confirmed that the present luminescent compound exhibits a high extinction coefficient and luminescence quantum yield in solution, although it depends on the solvent. One noteworthy point is that the present luminescent compound exhibits solvatochromism, and not only the absorption spectrum but also the emission spectrum changes significantly depending on the solvent. For example, in the case of FRF, the difference in the absorption maximum wavelength in methanol and dimethyl sulfoxide (DMSO) reaches more than 100 nm. Comparing the emission spectra in aprotic solvents, it was confirmed that, overall, the absorption wavelength and emission wavelength tend to shift to the longer wavelength side as the polarity of the solvent increases. Another noteworthy point is that it exhibits a very large Stokes shift. For example, FRπF exhibits a large Stokes shift of 310 nm in THF. Therefore, many of the present luminescent compounds exhibit strong emission on the longer wavelength side in solvents with relatively high polarity. Considering that light in the long wavelength (red region) has high biological permeability, these results suggest that the present luminescent compound is useful as a probe dye for bioimaging.

[0149] As representative examples, the results of measuring the fluorescence lifetimes of FπCM, FπA, and FCM in various solvents are summarized in Tables 11 to 13, respectively. In these tables, τ is the fluorescence lifetime, k r and k nr are the radiative and non-radiative decay rate constants, respectively. These results confirm that the luminescent compound shows a tendency to have stable luminescence regardless of the polarity environment, since there is almost no significant change in the rate constant regardless of the change in polarity.

[0150] [Table 11]

[0151] [Table 12]

[0152] [Table 13]

[0153] (2) Optical properties in the solid state It was confirmed that this luminescent compound emits strong fluorescence not only in solution but also in the solid state. As a representative example, a thin film was prepared by dispersing FπCM, FπA, or FRπF in a matrix of polymethyl methacrylate (PMM), and its fluorescence spectrum was measured. The thin film was prepared by preparing a THF solution containing PMMA with a number-average molecular weight of 100,000 and 1.0% of the luminescent substance, and casting the film on a quartz substrate. The wavelength of the excitation light was 370 nm. As is clear from the measurement results in Figure 11, these luminescent compounds give clear emission even in the solid state. The luminescence quantum yields of FπCM, FπA, and FRπF were 0.78, 0.38, and 0.13, respectively.

[0154] (3) Application as a bioimaging dye As model cells, DSPC (Ld), a saturated fatty acid model cell, and DOPC / Chol (Lo), an unsaturated fatty acid model cell, were stained with FπCM in DMSO solution (1 μM) at 37 °C for 5 minutes. The stained model cells were irradiated with excitation light (405 nm), and the obtained luminescence was separated into the blue region (400 nm to 500 nm) and the red region (500 nm to 700 nm) and acquired. As shown in Figure 12A, it was confirmed that there were compositions that showed blue luminescence and compositions that showed red luminescence. From this result, it was confirmed that FπCM gives different luminescence based on the difference in polarity of the model cells, that is, it is possible to distinguish and stain the difference in polarity of the model cells. This indicates that it is possible to image the inside of a cell based on the difference in polarity by spectrally analyzing the luminescence of the stained cells.

[0155] In fact, this was also demonstrated by the results of a similar treatment using mouse mammary epithelial cells (EpH4 cells). Specifically, mouse mammary epithelial cells were stained with a DMSO solution of FπCM (1 μM) at 37 °C for 5 minutes, and the stained mouse mammary epithelial cells were irradiated with excitation light (405 nm), and the resulting emission was separated into the blue region (400 nm to 500 nm) and the red region (500 nm to 700 nm) and acquired. (a) and (b) in Figure 12B are images obtained with the emission in the blue region and the red region, respectively. Image (d) is obtained by multiplying the brightness of the integrated image (c) by the intensity ratio of the red emission and the blue emission. As can be seen from the image (d), it is possible to image different emission colors for parts of different polarities in real cells as well.

[0156] (4) Evaluation of light resistance Commonly used fluorescent probes have low light resistance, making it difficult to perform bioimaging over a long period of time. In contrast, the present luminescent compound has high light resistance, and it has been found that it is capable of long-term bioimaging. For example, when a xenon lamp is used as a light source and a toluene solution of FπCM (10 μM) is continuously irradiated with excitation light (370 nm), it was confirmed that the fluorescence intensity remains almost unchanged for at least 7000 seconds (Figure 13). In contrast, when the light resistance of the common probe Prodan was examined under the same conditions, it was found that the fluorescence intensity decreased by about 20% after 7000 seconds. These results suggest that the present luminescent compound can be used as a probe with high light resistance.

[0157] The high light resistance of this luminescent compound was also confirmed in real cells. Specifically, using Lurdan and FπCM as probes, mouse mammary epithelial cells (EpH4 cells) were stained with a DMSO solution (10 μM) of the probe in 100 μL of HBSS (Hanks' Balanced Salt Solution) at 37 °C for 5 minutes, and then the solution containing the cells was diluted with 1 mL of HBSS. Images obtained by irradiating the obtained solution with a laser with an excitation light of 405 nm are shown in Figures 14A and 14B. Figures 14A and 14B are images obtained under the same imaging conditions using Lurdan and FπCM as probes, respectively, 0 minutes, 10 minutes, and 30 minutes after the start of excitation light irradiation. As is clear from these figures, when Lurdan was used as the probe, the emission intensity gradually decreased, and the contrast of the image after 30 minutes was very small. In contrast, when FπCM was used as the probe, the decrease in image brightness was extremely small, and it was confirmed that a high-contrast image could be obtained even 30 minutes after the start of excitation light irradiation. These results indicate that the present luminescent compound exhibits high light resistance even in bioimaging of real cells.

[0158] From the above, it is understood that the luminescent compound according to one embodiment of the present invention exhibits a large extinction coefficient and exhibits a high fluorescence quantum yield not only in a solution but also in a solid state. In addition, solvatochromism is observed with respect to the absorption and emission behavior, and the compound exhibits a very large Stokes shift depending on the solvent. Furthermore, since the compound has high light resistance, the luminescent compound is useful, for example, as a material for an electroluminescent device or a probe for bioimaging.

[0159] The above-described embodiments of the present invention may be combined as appropriate as long as they are not mutually inconsistent. Any embodiment in which a person skilled in the art appropriately adds or deletes components or modifies the design based on each embodiment is also included in the scope of the present invention as long as it includes the gist of the present invention.

[0160] Even if there are other effects and advantages different from those brought about by the respective embodiments described above, those which are clear from the description in this specification or which can be easily predicted by a person skilled in the art are naturally understood to be brought about by the present invention.

Claims

1. Represented by the following general formula (1): 【Chemistry 1】 W is hydrogen, an alkyl group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms; X is CR 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, S.O. 2 , or P.O.R. 6 and R 1 and R 2 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, or CH 2 CH 2 (O.C.H. 2 CH 2 ) n OCH 3 is a polyethylene glycol chain represented by n is an integer of 1 or more, R 3 , R 4 , and R 5 are independently a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a phenyl group, or a substituted phenyl group; R 6 is a phenyl group or a substituted phenyl group, the substituent of the substituted phenyl group is an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a diphenylamino group, or a monoalkylamino group or dialkylamino group in which the substituent on the nitrogen atom is an alkyl group having 1 to 8 carbon atoms; Y is an electron donating group; m is 0 or 1; Z is a formyl group, a carboxyl group, a cyano group, or a COR 7 , or CO 2 R 7 and R 7 is an alkyl group or a substituted alkyl group having 1 to 8 carbon atoms, A luminescent compound, wherein the substituent of the substituted alkyl group is a halogen atom, a hydroxyl group, an amino group, or an azide group.

2. The electron donating group is selected from an alkoxy group having 1 to 8 carbon atoms, and an amino group and a substituted amino group represented by the following structural formula: 【Chemistry 2】 R 8 , R 9 , R 10 , R 11 , and R 12 are independently hydrogen, an alkyl group or a substituted alkyl group having 1 to 10 carbon atoms; R 8 , R 9 , R 10 , R 11 , or R 12 When the alkyl group is a substituted alkyl group, the substituent is a halogen atom, a carboxyl group, an ethynyl group, an azido group, an amido group, an amino group, or a diphenylphosphinophenyl group, The luminescent compound according to claim 1 , wherein k is an integer of 1 or more and 4 or less.

3. R 8 , R 9 , R 10 , R 11 , or R 12 When R is the substituted alkyl group, 8 , R 9 , R 10 , R 11 , or R 12 3. The luminescent compound of claim 2, wherein the substituent on is located on a terminal carbon of the substituted alkyl group.

4. 2. The luminescent compound of claim 1, wherein W is hydrogen or a methyl group.

5. R 7 The luminescent compound according to claim 1 , wherein: is a perfluoroalkyl group.

6. The luminescent compound according to claim 5 , wherein the perfluoroalkyl group is a trifluoromethyl group.

7. The luminescent compound of claim 1 , wherein the substituent of the substituted alkyl group is located on a terminal carbon of the substituted alkyl group.

8. The luminescent compound according to claim 1 , wherein the number average molecular weight of the polyethylene glycol chain is 500 or more and 2,000 or less.

9. 2. The luminescent compound according to claim 1, wherein X is a dimethylmethylene group.

10. Represented by the following general formula (2): 【Chemistry 3】 W is hydrogen, an alkyl group having 1 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms; X 1 and X 2 are independently 1 R 2 , N.R. 3 , SiR 4 R 5 , O, S, S.O. 2 , or P.O.R. 6 and R 1 and R 2 are independently hydrogen, an alkyl group having 1 to 8 carbon atoms, or CH 2 CH 2 (O.C.H. 2 CH 2 ) n OCH 3 is a polyethylene glycol chain represented by n is an integer of 1 or more, R 3 , R 4 , and R 5 are independently a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a phenyl group, or a substituted phenyl group; R 6 is a phenyl group or a substituted phenyl group, the substituent of the substituted phenyl group is an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a diphenylamino group, or a monoalkylamino group or dialkylamino group in which the substituent on the nitrogen atom is an alkyl group having 1 to 8 carbon atoms; Y is an electron donating group; m is 0 or 1; Z is a formyl group, a carboxyl group, a cyano group, or a COR 7 , or CO 2 R 7 and R 7 is an alkyl group or a substituted alkyl group having 1 to 8 carbon atoms, A luminescent compound, wherein the substituent of the substituted alkyl group is a halogen atom, a hydroxyl group, an amino group, or an azide group.

11. The electron donating group is selected from an alkoxy group having 1 to 8 carbon atoms, and an amino group and a substituted amino group represented by the following structural formula: 【Chemistry 4】 R 8 , R 9 , R 10 , R 11 , and R 12 are independently hydrogen, an alkyl group or a substituted alkyl group having 1 to 10 carbon atoms; R 8 , R 9 , R 10 , R 11 , or R 12 When the alkyl group is a substituted alkyl group, the substituent is a halogen atom, a carboxyl group, an ethynyl group, an azido group, an amido group, an amino group, or a diphenylphosphinophenyl group, The luminescent compound according to claim 10 , wherein k is an integer of 1 or more and 4 or less.

12. R 8 , R 9 , R 10 , R 11 , or R 12 When R is the substituted alkyl group, 8 , R 9 , R 10 , R 11 , or R 12 12. The luminescent compound of claim 11, wherein the substituent on is located on a terminal carbon of the substituted alkyl group.

13. R 7 The luminescent compound according to claim 10 , wherein: is a perfluoroalkyl group.

14. The luminescent compound according to claim 13 , wherein the perfluoroalkyl group is a trifluoromethyl group.

15. The luminescent compound of claim 10 , wherein the substituent of the substituted alkyl group is located on a terminal carbon of the substituted alkyl group.

16. X 1 and X 2 The luminescent compound of claim 10 , wherein are the same as each other.

17. X 1 and X 2 The luminescent compound according to claim 10 , wherein each of